anybody trade this thing? stock was up 38% today on either an English or new england newspaper report that they are a couple months away from FDA approval for a SARS cure. after the close, bloomberg reported that the CEO, in response to the article, said it was completely false, and that they haven't even started testing on animals. where do you value the company and how long does it take to get FDA approval once testing starts (months, years)? stock up 38% to 7.00 today, then dropped about 20% to 6.00 afterhours? i'm leaning towards it being overpriced and a short, but even the hope for a cure gives it some value.